ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 251190 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 251190; 2) Community: the network communities that were significantly associated with the response to NSC 251190; 3) Molecule: the relationships between components within communities and NSC 251190; 4) MDR: the compounds that were significantly associated with the NSC 251190.

NSC Compound Enrichment Correlation
NSC 93135 OXYACANTHINE 0.00888636978630782 0.29719191
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.00888636978630788 0.34074231
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0102077332082016 0.1815779
NSC 606985 Camptothecin Derivative 0.0102077332082017 0.20512409
NSC 668269 Null 0.0102077332082017 0.43917235
NSC 676498 TP4EK-K6 0.0102077332082017 -0.14383317
NSC 686368 Quinazolin-4(3H)-one, 3-ethyl- 2-[[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]methyl]thio]- 0.0102077332082017 -0.36749042
NSC 686583 Null 0.0102077332082017 0.3212066
NSC 699940 Null 0.0102077332082017 0.079400841
NSC 720529 N-(6'-Chrysenyl)-4-(1'-piperidinyl)-D-2,3-dioxalono-butane-1 ,4-dicarboximide 0.0102077332082017 0.35155869
Total:56  Current:7    [First] [Prev] [Next] [Last]